About Us
Leadership Team
Dr. Jeffrey T. Jensen, MD, MPH
Founder & Chief Executive Officer
Renowned gynecologist and researcher with 35+ years in women’s health, previously at OHSU and currently leading development of gynecologic therapeutics.
Philberta Leung, PhD, PMP
Chief Operations Officer
Neuroscientist and certified project manager with biotech experience, expert in database, IP, and team coordination.
Jian Xin Guo, PhD
Chief Scientific Officer
Polymer chemist with a background at Johnson & Johnson and OHSU, specializing in foam-based therapeutic delivery systems.
Shula Jaron, PhD
Chief Business Officer
Seasoned biotechnology executive and entrepreneur with over 25 years of experience in research, product development, business development, and marketing.
Scientific Advisory Board
- Dr. David Archer – Clinical Trial Consultant: International expert in infertility, former president of multiple OB-GYN societies, active advisor since 2014.
- Dr. Charles Carignan – Product Development Consultant: Ex-CEO of multiple medtech companies, former CMO of Boston Scientific, extensive FDA and WHO experience.
- Bob Katz, MS, MBA – Product Development Consultant: CEO of ForwardVue Pharm, took VeraCept IUD from pre-clinical to Phase 3, business advisor for TSDS.
- Dr. Amy Thurmond – Clinical Consultant: Pioneer in HSG-based infertility treatment, radiologist with 35 years’ experience and TSDS trial collaborator.
- Dr. Lisa Rarick – Regulatory Consultant: Former FDA division director, now independent consultant, on OPERM advisory board since 2018.
- Dr. Don Waller – Toxicology Consultant: UIC Professor Emeritus, product developer of Phexi, expert in pharmacology and toxicology for women’s health.
Business Advisory Board
- Sabrina Johnson – CEO of Daré Bioscience: Serial entrepreneur focused on women’s healthcare, former CFO/COO of Woman Care Global Trading, potential TSDS acquirer.
- Dr. Brian A. Bernick – Chairman, Micron Biomedical: Co-founder of TherapeuticsMD, expert in clinical and commercial success of Annovera®, Bijuva®, and other women’s health products.
- Andrew Barofsky, JD, MBA – CEO, RevMedx: Oregon biotech innovator behind trauma care devices and ObstetRX; former OBI board chair.
- James Sailer – Co-President, Population Council: Led FDA approval and US launch of Annovera®. Heads global partnerships for contraceptive development and equitable access.